Astellas ISR Portal

At this time, Astellas is expediting the review of new Investigator Sponsored Research concepts related to the use of Astellas products in the management of COVID-19.Please submit COVID-19 requests for
ISRs through Astellas’ ISR portal (please Login, or click on Register Now,below).If you have questions or concerns related to your COVID-19 request (e.g., the product is not listed below as available for submi-
ssion to Astellas’ ISR portal), please email isrdevsupport@astellas.com

New research proposal submissions for the following products, regionally, will be reviewed for consideration of support by Astellas

Compound	Region/Country		Useful Hyperlinks
enfortumab vedotin	• United States (proposals will be reviewed jointly by Astellas and Seattle Genetics)		To view, click on the link below: ISR AREAS OF INTEREST
enzalutamide	• Asia (for country specific listing click here) • Australia • Canada • Europe (for country specific listing click here) • Japan • Latin America (for country specific listing click here)	• Russian Federation • South Africa • Turkey • United Arab Emirates • United States (proposals will be reviewed jointly by Astellas and Pfizer)
gilteritinib	• Asia (for country specific listing click here) • Australia • Canada • Europe (for country specific listing click here) • Japan	• Latin America (for country specific listing click here) • South Africa • United Arab Emirates • United States
isavuconazonium sulfate	• United States
mirabegron	• Asia • United States
ipragliflozin	• Japan		For Japan products, please click here: https://www.astellas.com/jp/isr/program.html
tacrolimus	• Asia (for country specific listing click here)

Please do not use this website to report safety information or product complaints. To report safety information or product complaints about an Astellas medicine please email according to region
For EMEA (Europe, Middle East and Africa) : safety-EU@astellas.com ; for Americas (Canada, USA and Latin America): safety-US@astellas.com ; or for Asia/Oceania (Japan, Australasia): safety-JP@astellas.com.

Welcome!

This is your place to manage all of your investigator-sponsored research with Astellas.